Efeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratos
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFS |
Texto Completo: | https://ri.ufs.br/handle/riufs/3866 |
Resumo: | Introduction: Hemorrhagic cystitis (HC) is the main side effect of cyclophosphamide (CP) chemotherapy. This condition is characterized by the macro and microhaematuria, dysuria, suprapubic pain and increased urinary frequency. It is believed that acrolein, a CP metabolite, induces the generation of reactive oxygen species in the uroepithelial cell, resulting in peroxynitrite formation, which can cause damage to these cells. Mesna is the choice drug used to prophylactically treat HC, because it prevents the acrolein contact with the uroepithelium. Besides, antioxidant substances are thought to have a protective effect on HC, mainly because of the reduction of peroxynitrite formation through the inhibition of superoxide production. In this way, natural compounds or extracts with antioxidant and anti-inflammatory properties may possess potential to treat HC. Objectives: In the present study the effect of the ethanol extract of the inner bark of Caesalpinia pyramidalis (EECp) was investigated in the HC model in rats. Methods: In order to induce HC, animals received an i.p. injection of CP (200 mg/kg). A control group received only saline (0.9%) by the same route. One hour before this injection, animals were pre-treated with vehicle (Tween 80, 5%, p.o.) or EECP (100-400 mg/kg, p.o.). Mesna was used as a control and was administrated 5 min before and 4 and 8 h after the CP injection. In this manner, there were used 6 experimental groups: (i) Vehicle+Saline; (ii) Vehicle+CP; (iii) EECp (100 mg/kg)+CP; (iv) EECp (200 mg/kg)+CP; (v) EECp (400 mg/kg)+CP; (vi) Mesna+CP. After 24 h of CP or saline injection, animals were euthanized and the inflammatory/oxidative parameters were measured: (i) myeloperoxidase (MPO) activity in the urinary bladder and lung tissues; (ii) malondialdehyde (MDA) concentration in the urinary bladder and lung tissues; (iii) edema index in bladder; (iv) serum concentrations of nitrite and nitrate; (v) total and differential leukocyte counts in the peripheral blood; (vi) histological analyses of the urinary bladder. Results: The injection of CP increased the MPO activity in the urinary bladder (P<0.001) and significantly altered all the histological parameters evaluated, when compared with the saline+vehicle group. Besides, it augmented the bladder weight (P<0.01), when compared with the saline+vehicle group, without changing the MDA concentrations. Systemically, we observed higher serum concentration of nitrite and nitrate and lung MPO activity, as wells as a decrease in the total leukocyte and mononuclear counts, with a slight increase in the polymorphonuclear counts (P<0.05), when compared with saline+vehicle group. Pre-treatment with EECp reduced the leukocyte influx to the urinary bladder, evidenced by the reduction of the MPO activity (P<0.001 for 100 and 400 mg/kg and P<0.05 for 200 mg/kg) and the histological score (P<0.05 for 100 mg/kg), accompanied by the diminution of the total histological score (P<0.05 for 100 mg/kg) and the basal concentration of MDA (P<0.05 for 100 and 400 mg/kg), when compared with the vehicle+CP group. It was also observed an attenuation of the lung injury caused by CP administration, by the reduction of the MPO activity (P<0.05 for 200 and 400 mg/kg) and basal MDA concentration (P<0.05 for 200 and 400 mg/kg), when compared with the vehicle+CP group. The pretreatment with EECp also reduced the serum concentration of the nitrate and nitrite (P<0.05 for 100 mg/kg and P<0.01 for 400 mg/kg), in addition to the polymorphonuclear cell counts (P<0.05 for all doses used), without any significant alteration in the total leukocyte and mononuclear counts. Conclusions: These results suggested that EECp possesses moderate anti-inflammatory and antioxidant effects on the HC and attenuates the CP-induced lung injury, being of interest for future studies involving therapeutical strategies to treat the effects associated with the chemotherapy with CP. |
id |
UFS-2_11f7199b49455454599efce7a7113a53 |
---|---|
oai_identifier_str |
oai:ufs.br:riufs/3866 |
network_acronym_str |
UFS-2 |
network_name_str |
Repositório Institucional da UFS |
repository_id_str |
|
spelling |
Matos, Alexandre Santoshttp://lattes.cnpq.br/2099198497076542Camargo, Enilton Aparecido2017-09-26T12:18:16Z2017-09-26T12:18:16Z2013-07-26MATOS, Alexandre Santos. Effect of ethanol extract of the inner bark of Caesalpinia pyramidalis Tul. on the hemorrhagic cystitis in rats. 2013. 97 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Sergipe, Aracaju, 2013.https://ri.ufs.br/handle/riufs/3866Introduction: Hemorrhagic cystitis (HC) is the main side effect of cyclophosphamide (CP) chemotherapy. This condition is characterized by the macro and microhaematuria, dysuria, suprapubic pain and increased urinary frequency. It is believed that acrolein, a CP metabolite, induces the generation of reactive oxygen species in the uroepithelial cell, resulting in peroxynitrite formation, which can cause damage to these cells. Mesna is the choice drug used to prophylactically treat HC, because it prevents the acrolein contact with the uroepithelium. Besides, antioxidant substances are thought to have a protective effect on HC, mainly because of the reduction of peroxynitrite formation through the inhibition of superoxide production. In this way, natural compounds or extracts with antioxidant and anti-inflammatory properties may possess potential to treat HC. Objectives: In the present study the effect of the ethanol extract of the inner bark of Caesalpinia pyramidalis (EECp) was investigated in the HC model in rats. Methods: In order to induce HC, animals received an i.p. injection of CP (200 mg/kg). A control group received only saline (0.9%) by the same route. One hour before this injection, animals were pre-treated with vehicle (Tween 80, 5%, p.o.) or EECP (100-400 mg/kg, p.o.). Mesna was used as a control and was administrated 5 min before and 4 and 8 h after the CP injection. In this manner, there were used 6 experimental groups: (i) Vehicle+Saline; (ii) Vehicle+CP; (iii) EECp (100 mg/kg)+CP; (iv) EECp (200 mg/kg)+CP; (v) EECp (400 mg/kg)+CP; (vi) Mesna+CP. After 24 h of CP or saline injection, animals were euthanized and the inflammatory/oxidative parameters were measured: (i) myeloperoxidase (MPO) activity in the urinary bladder and lung tissues; (ii) malondialdehyde (MDA) concentration in the urinary bladder and lung tissues; (iii) edema index in bladder; (iv) serum concentrations of nitrite and nitrate; (v) total and differential leukocyte counts in the peripheral blood; (vi) histological analyses of the urinary bladder. Results: The injection of CP increased the MPO activity in the urinary bladder (P<0.001) and significantly altered all the histological parameters evaluated, when compared with the saline+vehicle group. Besides, it augmented the bladder weight (P<0.01), when compared with the saline+vehicle group, without changing the MDA concentrations. Systemically, we observed higher serum concentration of nitrite and nitrate and lung MPO activity, as wells as a decrease in the total leukocyte and mononuclear counts, with a slight increase in the polymorphonuclear counts (P<0.05), when compared with saline+vehicle group. Pre-treatment with EECp reduced the leukocyte influx to the urinary bladder, evidenced by the reduction of the MPO activity (P<0.001 for 100 and 400 mg/kg and P<0.05 for 200 mg/kg) and the histological score (P<0.05 for 100 mg/kg), accompanied by the diminution of the total histological score (P<0.05 for 100 mg/kg) and the basal concentration of MDA (P<0.05 for 100 and 400 mg/kg), when compared with the vehicle+CP group. It was also observed an attenuation of the lung injury caused by CP administration, by the reduction of the MPO activity (P<0.05 for 200 and 400 mg/kg) and basal MDA concentration (P<0.05 for 200 and 400 mg/kg), when compared with the vehicle+CP group. The pretreatment with EECp also reduced the serum concentration of the nitrate and nitrite (P<0.05 for 100 mg/kg and P<0.01 for 400 mg/kg), in addition to the polymorphonuclear cell counts (P<0.05 for all doses used), without any significant alteration in the total leukocyte and mononuclear counts. Conclusions: These results suggested that EECp possesses moderate anti-inflammatory and antioxidant effects on the HC and attenuates the CP-induced lung injury, being of interest for future studies involving therapeutical strategies to treat the effects associated with the chemotherapy with CP.Introdução: A cistite hemorrágica (CH) é o principal efeito indesejado associado à quimioterapia com ciclofosfamida (CF). Esta condição é caracterizada pela presença de macro e micro hematúria, disúria, dor suprapúbica e aumento da frequência urinária. Acredita-se que a acroleína, metabólito da CF, induz a geração de espécies reativas de oxigênio no uroepitélio, resultando em CH. A prevenção desta patologia é feita com mesna, que atua impedindo o contato da acroleína com o uroepitélio. Entretanto, substâncias antioxidantes tem efeito protetor na CH e acredita-se que elas comprometam a produção de peroxinitrito por diminuir a produção de ânion superóxido e, desse modo, substâncias de origem natural com propriedades antioxidantes e anti-inflamatórias podem representar uma alternativa em potencial no tratamento da CH. O extrato etanólico de Caesalpinia pyramidalis (EECp) possui propriedades antioxidantes e anti-inflamatórias e, portanto, acredita-se que o mesmo possa modular vias inflamatórias envolvidas na CH. Objetivo: O presente estudo investigou o efeito do EECp na prevenção da CH induzida por CF. Métodos: A CH foi induzida pela injeção i.p. de CF (200 mg/kg) em ratos Wistar. Outro grupo recebeu somente salina (0,9%) pela mesma via. Os animais foram pré-tratados 1 h antes da injeção de CF ou salina com veículo (Tween 80 a 0,5%; v.o.) ou EECp (100-400 mg/kg; v.o.). O mesna foi administrado 5 min. antes e 4 e 8 h depois da indução da CH. Foram utilizados 6 grupos experimentais: (i) Veículo+Salina; (ii) Veículo+CF; (iii) EECp (100 mg/kg)+CF; (iv) EECp (200 mg/kg)+CF; (v) EECp (400 mg/kg)+CF; (vi) Mesna+CF. Após 24 h da injeção de CF ou salina os animais foram eutanasiados e alguns parâmetros inflamatórios foram medidos: (i) atividade de mieloperoxidase (MPO) na bexiga e no pulmão; (ii) concentração de malondialdeído (MDA) na bexiga e no pulmão; (iii) índice de edema na bexiga; (iv) concentrações séricas de nitrito e nitrato; (v) contagem total e diferencial de leucócitos em sangue periférico e (vi) análise histológica da bexiga. Resultados: A injeção de CF aumentou a atividade de MPO na bexiga (P<0,001) e alterou significativamente todos os parâmetros histopatológicos analisados, além de provocar aumento da massa da bexiga (P<0,01), sem alterar a concentração de MDA neste tecido, quando comparado ao grupo Veículo+Salina. Sistemicamente, observou-se elevação dos níveis séricos de nitrito e nitrato e da atividade de MPO pulmonar, bem como diminuição da contagem total de leucócitos e mononucleares, com aumento no número de polimorfonucleares, em relação ao grupo Veículo+Salina. O EECp causou a redução do influxo de leucócitos para a bexiga induzido pela CF, evidenciado pela diminuição do escore histológico (P<0,05 para 100 mg/kg) e a da atividade de MPO (P<0,001 para 100 e 400 mg/kg e P<0,05 para 200 mg/kg) na bexiga, acompanhado da diminuição do escore histológico total (P<0,05 para 100 mg/kg) e da concentração basal de MDA (P<0,05 para 100 e 400 mg/kg), quando comparado ao grupo Veículo+CF. Sistemicamente, a administração de EECp atenuou a lesão pulmonar induzida pela CF, demonstrada pela redução da atividade de MPO (P<0,05 para 200 e 400 mg/kg) e da concentração basal de MDA (P<0,05 para 200 e 400 mg/kg) neste tecido; reduziu as concentrações séricas de nitrito e nitrato (P<0,05 para 100 mg/kg e P<0,01 para 400 mg/kg) e diminuiu o número de leucócitos polimorfonucleares no sangue (P<0,05 para todas as doses usadas), quando comparado ao grupo Veículo+CF. Conclusão: Estes resultados permitem concluir que o EECp tem efeito anti-inflamatório e antioxidante moderados na CH, bem como atenua a lesão pulmonar induzida pela CF, podendo ser utilizado em estudos envolvendo estratégias terapêuticas futuras para o tratamento de efeitos associados à quimioterapia com CF.Coordenação de Aperfeiçoamento de Pessoal de Nível Superiorapplication/pdfporUniversidade Federal de SergipePós-Graduação em Ciências da SaúdeUFSBRCistite hemorrágicaCaesalpinia pyramidalisCiclofosfamidaHemorrhagic cystitisCyclophosphamideCaesalpinia pyramidalisCNPQ::CIENCIAS DA SAUDEEfeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratosEffect of ethanol extract of the inner bark of Caesalpinia pyramidalis Tul. on the hemorrhagic cystitis in ratsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFSinstname:Universidade Federal de Sergipe (UFS)instacron:UFSTEXTALEXANDRE_SANTOS_MATOS.pdf.txtALEXANDRE_SANTOS_MATOS.pdf.txtExtracted texttext/plain183664https://ri.ufs.br/jspui/bitstream/riufs/3866/2/ALEXANDRE_SANTOS_MATOS.pdf.txt97fa63c671d24bbf6af1bc891bb246a2MD52THUMBNAILALEXANDRE_SANTOS_MATOS.pdf.jpgALEXANDRE_SANTOS_MATOS.pdf.jpgGenerated Thumbnailimage/jpeg1357https://ri.ufs.br/jspui/bitstream/riufs/3866/3/ALEXANDRE_SANTOS_MATOS.pdf.jpg4a20be035f5f64f167349aaf948787daMD53ORIGINALALEXANDRE_SANTOS_MATOS.pdfapplication/pdf5932093https://ri.ufs.br/jspui/bitstream/riufs/3866/1/ALEXANDRE_SANTOS_MATOS.pdf142ab33963de1d707333ae8c6abe5766MD51riufs/38662017-11-28 16:35:59.89oai:ufs.br:riufs/3866Repositório InstitucionalPUBhttps://ri.ufs.br/oai/requestrepositorio@academico.ufs.bropendoar:2017-11-28T19:35:59Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)false |
dc.title.por.fl_str_mv |
Efeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratos |
dc.title.alternative.eng.fl_str_mv |
Effect of ethanol extract of the inner bark of Caesalpinia pyramidalis Tul. on the hemorrhagic cystitis in rats |
title |
Efeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratos |
spellingShingle |
Efeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratos Matos, Alexandre Santos Cistite hemorrágica Caesalpinia pyramidalis Ciclofosfamida Hemorrhagic cystitis Cyclophosphamide Caesalpinia pyramidalis CNPQ::CIENCIAS DA SAUDE |
title_short |
Efeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratos |
title_full |
Efeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratos |
title_fullStr |
Efeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratos |
title_full_unstemmed |
Efeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratos |
title_sort |
Efeito do extrato etanólico da entrecasca de Caesalpinia pyramidalis Tul. na cistite hemorrágica em ratos |
author |
Matos, Alexandre Santos |
author_facet |
Matos, Alexandre Santos |
author_role |
author |
dc.contributor.author.fl_str_mv |
Matos, Alexandre Santos |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/2099198497076542 |
dc.contributor.advisor1.fl_str_mv |
Camargo, Enilton Aparecido |
contributor_str_mv |
Camargo, Enilton Aparecido |
dc.subject.por.fl_str_mv |
Cistite hemorrágica Caesalpinia pyramidalis Ciclofosfamida |
topic |
Cistite hemorrágica Caesalpinia pyramidalis Ciclofosfamida Hemorrhagic cystitis Cyclophosphamide Caesalpinia pyramidalis CNPQ::CIENCIAS DA SAUDE |
dc.subject.eng.fl_str_mv |
Hemorrhagic cystitis Cyclophosphamide Caesalpinia pyramidalis |
dc.subject.cnpq.fl_str_mv |
CNPQ::CIENCIAS DA SAUDE |
description |
Introduction: Hemorrhagic cystitis (HC) is the main side effect of cyclophosphamide (CP) chemotherapy. This condition is characterized by the macro and microhaematuria, dysuria, suprapubic pain and increased urinary frequency. It is believed that acrolein, a CP metabolite, induces the generation of reactive oxygen species in the uroepithelial cell, resulting in peroxynitrite formation, which can cause damage to these cells. Mesna is the choice drug used to prophylactically treat HC, because it prevents the acrolein contact with the uroepithelium. Besides, antioxidant substances are thought to have a protective effect on HC, mainly because of the reduction of peroxynitrite formation through the inhibition of superoxide production. In this way, natural compounds or extracts with antioxidant and anti-inflammatory properties may possess potential to treat HC. Objectives: In the present study the effect of the ethanol extract of the inner bark of Caesalpinia pyramidalis (EECp) was investigated in the HC model in rats. Methods: In order to induce HC, animals received an i.p. injection of CP (200 mg/kg). A control group received only saline (0.9%) by the same route. One hour before this injection, animals were pre-treated with vehicle (Tween 80, 5%, p.o.) or EECP (100-400 mg/kg, p.o.). Mesna was used as a control and was administrated 5 min before and 4 and 8 h after the CP injection. In this manner, there were used 6 experimental groups: (i) Vehicle+Saline; (ii) Vehicle+CP; (iii) EECp (100 mg/kg)+CP; (iv) EECp (200 mg/kg)+CP; (v) EECp (400 mg/kg)+CP; (vi) Mesna+CP. After 24 h of CP or saline injection, animals were euthanized and the inflammatory/oxidative parameters were measured: (i) myeloperoxidase (MPO) activity in the urinary bladder and lung tissues; (ii) malondialdehyde (MDA) concentration in the urinary bladder and lung tissues; (iii) edema index in bladder; (iv) serum concentrations of nitrite and nitrate; (v) total and differential leukocyte counts in the peripheral blood; (vi) histological analyses of the urinary bladder. Results: The injection of CP increased the MPO activity in the urinary bladder (P<0.001) and significantly altered all the histological parameters evaluated, when compared with the saline+vehicle group. Besides, it augmented the bladder weight (P<0.01), when compared with the saline+vehicle group, without changing the MDA concentrations. Systemically, we observed higher serum concentration of nitrite and nitrate and lung MPO activity, as wells as a decrease in the total leukocyte and mononuclear counts, with a slight increase in the polymorphonuclear counts (P<0.05), when compared with saline+vehicle group. Pre-treatment with EECp reduced the leukocyte influx to the urinary bladder, evidenced by the reduction of the MPO activity (P<0.001 for 100 and 400 mg/kg and P<0.05 for 200 mg/kg) and the histological score (P<0.05 for 100 mg/kg), accompanied by the diminution of the total histological score (P<0.05 for 100 mg/kg) and the basal concentration of MDA (P<0.05 for 100 and 400 mg/kg), when compared with the vehicle+CP group. It was also observed an attenuation of the lung injury caused by CP administration, by the reduction of the MPO activity (P<0.05 for 200 and 400 mg/kg) and basal MDA concentration (P<0.05 for 200 and 400 mg/kg), when compared with the vehicle+CP group. The pretreatment with EECp also reduced the serum concentration of the nitrate and nitrite (P<0.05 for 100 mg/kg and P<0.01 for 400 mg/kg), in addition to the polymorphonuclear cell counts (P<0.05 for all doses used), without any significant alteration in the total leukocyte and mononuclear counts. Conclusions: These results suggested that EECp possesses moderate anti-inflammatory and antioxidant effects on the HC and attenuates the CP-induced lung injury, being of interest for future studies involving therapeutical strategies to treat the effects associated with the chemotherapy with CP. |
publishDate |
2013 |
dc.date.issued.fl_str_mv |
2013-07-26 |
dc.date.accessioned.fl_str_mv |
2017-09-26T12:18:16Z |
dc.date.available.fl_str_mv |
2017-09-26T12:18:16Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
MATOS, Alexandre Santos. Effect of ethanol extract of the inner bark of Caesalpinia pyramidalis Tul. on the hemorrhagic cystitis in rats. 2013. 97 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Sergipe, Aracaju, 2013. |
dc.identifier.uri.fl_str_mv |
https://ri.ufs.br/handle/riufs/3866 |
identifier_str_mv |
MATOS, Alexandre Santos. Effect of ethanol extract of the inner bark of Caesalpinia pyramidalis Tul. on the hemorrhagic cystitis in rats. 2013. 97 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Sergipe, Aracaju, 2013. |
url |
https://ri.ufs.br/handle/riufs/3866 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Sergipe |
dc.publisher.program.fl_str_mv |
Pós-Graduação em Ciências da Saúde |
dc.publisher.initials.fl_str_mv |
UFS |
dc.publisher.country.fl_str_mv |
BR |
publisher.none.fl_str_mv |
Universidade Federal de Sergipe |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFS instname:Universidade Federal de Sergipe (UFS) instacron:UFS |
instname_str |
Universidade Federal de Sergipe (UFS) |
instacron_str |
UFS |
institution |
UFS |
reponame_str |
Repositório Institucional da UFS |
collection |
Repositório Institucional da UFS |
bitstream.url.fl_str_mv |
https://ri.ufs.br/jspui/bitstream/riufs/3866/2/ALEXANDRE_SANTOS_MATOS.pdf.txt https://ri.ufs.br/jspui/bitstream/riufs/3866/3/ALEXANDRE_SANTOS_MATOS.pdf.jpg https://ri.ufs.br/jspui/bitstream/riufs/3866/1/ALEXANDRE_SANTOS_MATOS.pdf |
bitstream.checksum.fl_str_mv |
97fa63c671d24bbf6af1bc891bb246a2 4a20be035f5f64f167349aaf948787da 142ab33963de1d707333ae8c6abe5766 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS) |
repository.mail.fl_str_mv |
repositorio@academico.ufs.br |
_version_ |
1802110659169615872 |